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Background
Adherence to protective cardiovascular medications is of
huge importance in the prevention of serious morbidity
and mortality [1]. This study seeks to identify factors
that influence adherence to the treatment of cardiovas-
cular medications and to analyse the characteristics of
the baseline non-adherence Irish cohort of the UMPIRE
study. UMPIRE (“Use of a Multidrug Pill In Reducing
cardiovascular Events”) was a prospective, randomised,
open-label, blinded-endpoint (PROBE) clinical trial car-
ried out in three locations in Europe (Ireland, The Neth-
erlands and the UK) as well as India. The Irish cohort
was a total of 333 participants (total trial 2,004 of which
half in India). It had a key eligibility criterion of estab-
lished cardiovascular disease (CVD) or an estimated 5-
year CVD risk of ≥15%. The results were present at the
American Heart Association 2012 Scientific Sessions.
Methods
A literature review was carried out to identify evidence
for factors affecting adherence in the treatment of
hypertension. A database of patient profiles and health
measurements was created and analysed using Excel and
DataDesk. The unpaired Students t-tests and Chi-
squared tests were used to test for differences between
baseline adherent and non-adherent groups and the
results were then compared with expectation from the
literature review.
Results
Several significant factors affecting adherence were sug-
gested from the analysis of the Irish UMPIRE cohort.
Younger age, a higher educational status and a lack of a
Medical card were associated with non-adherence.
There was a trend, consistent with the UMPIRE study,
for higher systolic blood pressure, heart rate and LDL
cholesterol levels in the non-adherent cohort as would
be expected.
Conclusions
Economic pressures appear to be a significant predictor of
adherence which may account for the contrary findings to
the literature review on age and educational status. In the
Irish context, this might be attributed to younger middle
income individuals having greater financial liabilities than
their older peers on average.
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